Pharmacal Recalls One Lot of MG217 Eczema Cream Over Staph Contamination

Overview

• Pharmacal launched a nationwide recall after testing found Staphylococcus aureus in one lot of MG217 Multi-symptom Treatment Cream.
• The affected 6-ounce tubes are labeled with product code 5106, UPC 012277051067, lot 1024088, and an expiration date of November 2026, with the lot number printed on the crimped end of the tube.
• The product was distributed to retailers and online sellers, including Amazon, and the company is notifying distributors and arranging returns.
• The FDA says use could cause infections that range from skin irritation to severe illness, especially for people with weakened immune systems or compromised skin.
• No adverse events have been reported to date, and consumers are urged to stop use, discard the product, seek medical care for symptoms, and report problems to FDA MedWatch.